Sanofi Sues HHS, HRSA for Contract Details Between Covered Entities, Pharmacies

Drug manufacturer Sanofi has sued the federal government for information about contracts between covered entities and contract pharmacies.
French drugmaker Sanofi recently filed suit against federal agencies seeking details from contracts between 340B covered entities and outside pharmacies. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

In Stinging Op-Ed, West Virginia Senate Leader Bashes Drug Industry and Rejects Efforts to Politicize 340B Program

West Virginia Senate President Craig Blair (R), who also serves as the state’s lieutenant governor, told 340B Report that he’s weighing potential litigation against Stand for Us PAC, which has claimed credit for the GOP leader’s May 14 primary loss. (Photo courtesy: WV Senate.)
A key West Virginia lawmaker this week hit back against efforts to tie the 340B program to partisan politics, arguing [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Super PAC with Dark Money Ties Launches New Anti-340B Ad

Stand for Us PAC's latest ad threatens Republican politicians that support 340B and claims disputed credit for a key West Virginia lawmaker's recent primary loss.
A political action committee (PAC) with close ties to a dark money group recently released a new ad threatening to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Range of Motives Likely Behind Surge in Drugmaker Contract Pharmacy Changes, Say Provider Advisers

Jason Reddish, a principal at Powers Law who represents covered entities, said drugmakers were "emboldened" by recent federal court decisions to issue contract pharmacy restrictions.
A surge of recent drug manufacturer contract pharmacy policy changes may be driven by recent legal developments, new state laws, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Draft Senate Drug Shortages Bill Sparks Stakeholder Debate over 340B Provisions

Stakeholders recently submitted feedback on a draft Senate Finance Committee drug shortages bill with 340B implications.
A draft Senate bill, which would offer bonus payments to hospitals that stockpile certain generic drugs and forgo other rebates [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Supreme Court to Review Case that Could Result in More Hospitals Qualifying for 340B Program

Supreme Court Justices announced in a June 10 order that they’d review the U.S. Court of Appeals for the D.C. Circuit’s September 2023 decision in Advocate Christ Medical Center v. Becerra.
The U.S. Supreme Court this week agreed to take on a case that potentially could expand the number of hospitals [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

340B INDUSTRY LEADER SPOTLIGHT

Jason Atlas, Senior Vice President, Pharmacy Operations, Maxor National Pharmacy Services

Jason Atlas

Q: Where did you grow up?

Princeton NJ.  My father and his twin brother owned and operated an independent pharmacy for over 40 years, and obviously pharmacy runs in the family.

Q: Where did you go to college/graduate school?

I graduated from the Ernest Mario School of Pharmacy, Rutgers University and then completed my Masters in Business Administration

Read More »

Expert Tip from RxStrategies

img
img

TIP: Dedicating resources and ensuring team members have access to education & information are essential to successfully navigating the 340B program.

Read More »

Federal Judge Presses Drug Industry on Preemption Arguments During Key Hearing on Louisiana 340B Law

Attorneys representing the drug industry, the state of Louisiana, and Louisiana health centers presented oral arguments before a federal district court.
A federal judge late last week pressed drug industry attorneys on their claims that Louisiana’s 340B contract pharmacy law oversteps [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Organon Ends or Loosens 340B Contract Pharmacy Restrictions in Four More States

Drugmaker Organon fully exempted West Virginia providers from its contract pharmacy policy and loosened its restrictions in three additional states.
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, is now fully exempting West Virginia covered [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live